Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Lucid Diagnostics (LUCD) Operating Expenses (2021 - 2025)

Lucid Diagnostics (LUCD) has disclosed Operating Expenses for 5 consecutive years, with $13.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Operating Expenses rose 0.81% year-over-year to $13.0 million, compared with a TTM value of $52.4 million through Sep 2025, up 6.25%, and an annual FY2024 reading of $50.4 million, down 1.01% over the prior year.
  • Operating Expenses was $13.0 million for Q3 2025 at Lucid Diagnostics, up from $12.5 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $15.1 million in Q4 2022 and bottomed at $3.7 million in Q1 2021.
  • Average Operating Expenses over 5 years is $11.8 million, with a median of $12.5 million recorded in 2023.
  • The sharpest move saw Operating Expenses soared 241.09% in 2022, then decreased 20.12% in 2024.
  • Year by year, Operating Expenses stood at $11.5 million in 2021, then surged by 31.02% to $15.1 million in 2022, then dropped by 17.37% to $12.5 million in 2023, then rose by 8.64% to $13.6 million in 2024, then decreased by 4.44% to $13.0 million in 2025.
  • Business Quant data shows Operating Expenses for LUCD at $13.0 million in Q3 2025, $12.5 million in Q2 2025, and $13.3 million in Q1 2025.